Skip to content

Post-Surgical Mediastinitis Within the CHU Brugmann Hospital

Post-Surgical Mediastinitis: Retrospective Study of Cases Treated Within the CHU Brugmann Hospital

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03922191
Enrollment
19
Registered
2019-04-19
Start date
2019-02-12
Completion date
2019-07-15
Last updated
2019-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mediastinitis

Brief summary

Mediastinitis is an infectious complication that can occur after cardiac surgery. The incidence varies between 1 and 3% depending on the type of procedure and the patient's condition. The mortality of this severe postoperative complication rises from 10 to 35%, which makes it dreadful. The major risk factors reported are obesity, diabetes, and immunosuppressive therapy. There are other less important ones: age, coronary bypass grafting (especially if using the two internal mammary arteries), nosocomial pneumonia, dialysis, prolonged mechanical ventilation, long operative asepsis, undrained retro-sternally hematoma, prolonged pre-operative hospitalization...). Prevention is very important. The principle of asepsis must absolutely be respected. The use of prophylactic antibiotic therapy is recommended. The most commonly encountered organisms are Staphylococcus aureus, coagulase-negative Staphylococci and gram-negative bacilli. There are several treatment modalities that vary between centers and may be different depending on the surgical team's experience and the depth or extent of the infection. The common principles of these treatments are: antibiotic therapy and surgical debridement (the timing of which may vary). The timing and modalities of wound closure are subject to variations: immediate sternal closure with placement of multiple or delayed drains. Muscle flaps or large omentum transplant may be necessary if tissue loss is too important. The investigators propose to review their experience in the treatment of cardiac post-surgery mediastinitis at Brugmann University Hospital in the last 20 years in both adult and pediatric patients.

Interventions

Data extraction from medical files

Sponsors

Pierre Wauthy
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* post-cardiac surgery mediastinitis * patients of the CHU Brugmann (adults) and HUDERF (pediatric) Hospitals

Exclusion criteria

\- none

Design outcomes

Primary

MeasureTime frameDescription
Presence of superinfection20 yearsPresence of superinfection
Duration of the hospitalization20 yearsDuration of the hospitalization
Mortality at six months6 monthsMortality rate six months after mediastinitis diagnosis
Percentage of recurrence20 yearsPercentage of recurrence of mediastinitis
Percentage of re-hospitalization20 yearsPercentage of re-hospitalizations caused by mediastinitis
Duration of the antibiotic treatment20 yearsDuration of the antibiotic treatment for mediastinitis

Secondary

MeasureTime frameDescription
Date of birth20 yearsDemographic data : Date of birth.
Sex20 yearsDemographic data : sex.
Risk factors20 yearsDemographic data : presence of risk factors (obesity, diabetes...).
Surgical intervention20 yearsName of the surgical intervention that caused the mediastinitis
Germ identification20 yearsName of the germ causing the mediastinitis
Type of treatment20 yearsName of the antibiotics used to treat the mediastinitis

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026